Cargando…
Assuring Access to Safe Medicines in Pregnancy and Breastfeeding
Scientists and regulators in Europe and the United States continue to seek methods and strategies to improve knowledge on rational use of medicines for pregnant and breastfeeding populations, an important subset of women’s health. Regulatory agencies have made strides toward improvement, but much mo...
Autores principales: | Nooney, Janet, Thor, Shannon, de Vries, Corinne, Clements, John, Sahin, Leyla, Hua, Wei, Everett, Darcie, Zaccaria, Cosimo, Ball, Robert, Saint‐Raymond, Agnes, Yao, Lynne, Raine, June, Kweder, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518426/ https://www.ncbi.nlm.nih.gov/pubmed/33615448 http://dx.doi.org/10.1002/cpt.2212 |
Ejemplares similares
-
EMA-FDA Parallel Scientific Advice: Optimizing Development of Medicines in the Global Age
por: Thor, Shannon, et al.
Publicado: (2023) -
Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?
por: Teixeira, Tania, et al.
Publicado: (2019) -
Considering Global Development? Insights from Applications for FDA Breakthrough Therapy and EMA PRIME Designations
por: Hanaizi, Zahra, et al.
Publicado: (2022) -
Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework
por: Renaud, Françoise, et al.
Publicado: (2022) -
Chronic use of psychotropic medications in breastfeeding women: Is it safe?
por: Kronenfeld, Nirit, et al.
Publicado: (2018)